广州社区中老年人群肥胖、身体活动与血清肝功能指标的相关性研究

doi:10.12183/j.scjpm.2024.0199

摘要/Abstract

摘要： 目的分析广州社区中老年人群肥胖、身体活动与血清肝功能指标的关联。方法基于广州生物库队列研究数据,采用多元线性回归模型分析中心性肥胖、全身性肥胖和身体活动与血清肝功能指标的关联性。通过加入交互作用项评估肥胖与身体活动的交互作用对肝功能指标的影响。结果纳入了8 714名参与者,平均年龄（64.65±6.05）岁。女性6 251人（71.74%）,男性2 463人（28.26%）。相对非中心性肥胖组,中心性肥胖具有高谷丙转氨酶（ALT）和谷草转氨酶（AST）水平以及低白蛋白（ALB）水平,回归系数β分别为4.74、0.66、-0.27 IU/L（均P<0.01）。相对非全身性肥胖组,全身性肥胖具有高ALT和AST水平以及低ALB水平,回归系数β分别为5.72、1.23、-0.36 IU/L（均P<0.01）。相对身体活动活跃组,非活跃组的AST水平较高,回归系数β为0.53 IU/L（P<0.01）。结论中心性肥胖、全身性肥胖及低身体活动水平与血清肝功能指标异常存在显著关联,提示肥胖管理、增加体力活动对于维持肝功能水平的重要性。

关键词: 肥胖, 体力活动, 肝功能指标

Abstract: Objective To analyze the correlation of obesity and physical activity with serum liver function indicators in the middle-aged and elderly population in Guangzhou. Methods Based on the data of Guangzhou Biobank Cohort Study,multiple linear regression model was used to analyze the correlation of central obesity,systemic obesity,and physical activity with various serum liver function indicators. The effects of the interaction between obesity and physical activity on liver function indicators were evaluated by adding interaction terms. Results A total of 8 714 participants with a mean age of （64.65±6.05）years were included. There were 6 251 females （71.74%）and 2 463 males （28.26%）. Compared with the non-central obesity group,the central obesity group had higher alanine aminotransferase （ALT）and aspartate aminotransferase （AST）levels,and lower albumin （ALB）levels,and the regression coefficients β were 4.74,0.66,and -0.27 IU/L,respectively （all P < 0.01）. Compared with the non-systemic obesity group,the systemic obesity group had higher ALT and AST levels and lower ALB levels,and the regression coefficients β were 5.72,1.23,and -0.36 IU/L,respectively （all P < 0.01）. AST levels in inactive group were higher than those in active group,and the regression coefficient β was 0.53 IU/L （P < 0.01）. Conclusion Central obesity,systemic obesity,and low physical activity level were significantly correlated with abnormal serum liver function indicators,suggesting the importance of obesity management and increasing physical activity in maintaining liver function.

Key words: Obesity, Physical activity, Liver function indicator

中图分类号:

R195

张青, 张维森, 江朝强, 靳雅丽, 徐琳. 广州社区中老年人群肥胖、身体活动与血清肝功能指标的相关性研究[J]. 华南预防医学, 2024, 50(3): 199-204.

ZHANG Qing, ZHANG Weisen, JIANG Zhaoqiang, JIN Yali, XU Lin. Correlation of obesity and physical activity with serum liver function indicators in middle-aged and elderly population in Guangzhou[J]. South China Journal of Preventive Medicine, 2024, 50(3): 199-204.

参考文献

[1] Kwasnicka D,Ntoumanis N,Hunt K,et al.A gender-sensitised weight-loss and healthy living program for men with overweight and obesity in Australian Football League settings (Aussie-FIT):A pilot randomised controlled trial[J]. PLoS Med,2020,17(8):e1003136.
[2] 国家卫生健康.委中国居民营养与慢性病状况报告(2020年)[J].营养学报,2020,42(6):521.
[3] Li W,Homer K,Hull S,et al.Obesity predicts liver function testing and abnormal liver results[J]. Obesity (Silver Spring),2020,28(1):132-138.
[4] Carter AR,Borges MC,Benn M,et al.Combined association of body mass index and alcohol consumption with biomarkers for liver injury and incidence of liver disease:A mendelian randomization study[J].JAMA Netw Open,2019,2(3):e190305.
[5] Lee EY,Choi HY,Cho H,et al.Health behavior associated with liver enzymes among obese Korean adolescents,2009-2014[J]. PLoS One,2018,13(1):e0190535.
[6] Chu LM,Karunanayake C,Aich P,et al.Association between liver enzymes and metabolic syndrome in Canadian adults:Results from the Canadian health measures survey-cycles 3 &4[J].J Diabetes Metab Disord,2022,21(2):1699-1708.
[7] Kim D,Vazquez-Montesino LM,Li AA,et al.Inadequate physical activity and sedentary behavior are independent predictors of nonalcoholic fatty liver disease[J]. Hepatology,2020,72(5):1556-1568.
[8] Younossi ZM,Zelber-Sagi S,Henry L,et al.Lifestyle interventions in nonalcoholic fatty liver disease[J].Nat Rev Gastroenterol Hepatol,2023,20(11):708-722.
[9] Niemelä O,Bloigu A,Bloigu R,et al.Associations between liver enzymes,lifestyle risk factors and pre-existing medical conditions in a population-based cross-sectional sample[J].J Clin Med,2023,12(13):4276.
[10] Jiang C,Thomas GN,Lam TH,et al.Cohort profile:The Guangzhou Biobank Cohort Study,a Guangzhou-Hong Kong-Birmingham collaboration[J].Int J Epidemiol,2006,35(4):844-852.
[11] 尤红,王福生,李太生,等.慢性乙型肝炎防治指南(2022年版)[J].实用肝脏病杂志,2023,26(3):457-478.
[12] 黄楚妮,肖俊锐,吴石贵.血清生化指标对非酒精性脂肪性肝病患者肝功能损伤的临床价值[J].深圳中西医结合杂志,2020,30(6):71-72.
[13] 刘芳,季良,陈男男,等.PAB、ALB、TBIL、TBA、AST在乙型肝炎不同并发症阶段检测意义分析[J].中国现代医生,2021,59(15):5-8.
[14] 中国营养学会肥胖防控分会,中国营养学会临床营养分会,中华预防医学会行为健康分会,等.中国居民肥胖防治专家共识[J].中国预防医学杂志,2022,23(5):321-339.
[15] Liang X,Zhang WS,Jin YL,et al.Association of multi-dimensional factors with accelerating age and constructing a healthy lifestyle index:Guangzhou Biobank Cohort Study[J]. Gerontology,2023,69(6):737-747.
[16] 卢岸婷,张维森,江朝强,等.代谢综合征与主动脉弓钙化的关联性研究:广州生物库队列研究[J].中华疾病控制杂志,2022,26(8):939-944.
[17] 沈振敏,江朝强,张维森,等.基于广州生物库的广州市中老年人饮酒行为改变及其影响因素的前瞻性队列研究[J].中国慢性病预防与控制,2018,26(3):161-166.
[18] Ren YJ,Su M,Liu QM,et al.Validation of the simplified Chinese-character version of the International Physical Activity Questionnaire-Long Form in Urban community-dwelling adults:A cross-sectional study in Hangzhou,China[J]. Biomed Environ Sci,2017,30(4):255-263.
[19] 李建军. 《中国血脂管理指南(2023年)》核心要点解读[J].临床心血管病杂志,2023,39(7):491-494.
[20] 中国老年医学学会高血压分会,北京高血压防治协会,国家老年疾病临床医学研究中心(中国人民解放军总医院,首都医科大学宣武医院等).中国老年高血压管理指南2023[J].中华高血压杂志,2023,31(6):508-538.
[21] 赵维纲. 《中国老年2型糖尿病防治临床指南(2022年版)》解读[J].协和医学杂志,2022,13(4):574-580.
[22] Heeren J,Scheja L.Metabolic-assoclted fatty liver disease and lipoprotein metabolism[J]. Mol Metab,2021,50:101238.
[23] Zhao YC,Zhao GJ,Chen Z,et al.Nonalcoholic fatty liver disease:An emerging driver of hypertension[J].Hypertension,2020,75(2):275-284.
[24] Kogiso T,Sagawa T,Kodama K,et al.Development and course of diabetes according to genetic factors and diabetes treatment among patients with nonalcoholic fatty liver disease[J]. Nutrition,2021,83:111080.
[25] Lee YH,Jang HJ,Kim S,et al.Hepatic MIR20B promotes nonalcoholic fatty liver disease by suppressing PPARA[J]. Elife,2021,10:e70472.
[26] Thibaut R,Gage MC,Pineda-Torra I,et al.Liver macrophages and inflammation in physiology and physiopathology of non-alcoholic fatty liver disease[J].FEBS J,2022,289(11):3024-3057.
[27] Abdollahi A,Narayanan SK,Frankovich A,et al.Albumin deficlency reduces hepatic steatosis and improves glucose metabolism in a mouse model of diet-induced obesity[J]. Nutrients,2023,15(9):2060.
[28] Fu J,Wang Q,Zhang L,et al.Serum bilirubin level is increased in metabolically healthy obesity[J]. Front Endocrinol (Lausanne),2022,12:792795.
[29] 刘莹莹,刘玉萍,刘佑韧,等.代谢相关脂肪性肝病患者有氧运动干预实施的前瞻性研究[J].临床肝胆病杂志,2020,36(11 ):2467-2472 .
[30] 黄伟. 联合运动对非酒精性脂肪性肝病患者肝脏脂肪含量的影响及代谢灵活性的作用[D].上海:上海体育学院,2023.
[31] Grønbæk H,Lange A,Birkebæk NH,et al.Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children[J].J Pediatr Gastroenterol Nutr,2012,54(2):223-228.
[32] Iraji H,Minasian V,Kelishadi R.Changes in liver enzymes and metabolic profile in adolescents with fatty liver following exercise interventions[J].Pediatr Gastroenterol Hepatol Nutr,2021,24(1):54-64.
[33] von Loeffelholz C,Roth J,Coldewey SM,et al. The role of physical activity in nonalcoholic and metabolic dysfunction associated fatty liver disease[J].Biomedicines,2021,9(12):1853.